Johnson & Johnson Sees Unusual Options Activity as $1.1M Call Dominates Flow With Stock Near 52-Week Highs

By TrendSpider Editor

Johnson & Johnson is drawing attention in the options market today, with a single call contract accounting for over $1.1 million in premium out of $1,252,285 in total unusual options flow detected across four contracts. JNJ shares are trading at $255.75, up 2.03% on the session, and sitting comforta

Johnson & Johnson Sees Unusual Options Activity as $1.1M Call Dominates Flow With Stock Near 52-Week Highs

Johnson & Johnson is drawing attention in the options market today, with a single call contract accounting for over $1.1 million in premium out of $1,252,285 in total unusual options flow detected across four contracts. JNJ shares are trading at $255.75, up 2.03% on the session, and sitting comfortably in the upper half of their 52-week range of $162.78 to $269.43. The dominant call strike is in-the-money and targets a nearly one-year expiration, suggesting that at least one large market participant is making a meaningful directional bet on continued upside through mid-2027.

Key Drivers of the JNJ Stock Move

• Main Catalyst: Four unusual options contracts were flagged today with a combined total premium of $1,252,285. The headline trade is a call at the $230 strike expiring June 17, 2027, with 290 contracts traded against an open interest reading of 236%, indicating volume well above existing positions. On the put side, a July 31, 2026 put at the $242.50 strike printed 571 contracts at 656% of open interest, with two additional long-dated puts at the $250 and $195 strikes expiring December 15, 2028.
• Bull Case: The $230 call expiring June 2027 is currently in-the-money with JNJ trading at $255.75, and the $1,113,600 premium committed to that single contract reflects a high-conviction position. With the stock only about $13.68 below its 52-week high of $269.43, the call buyer appears positioned for a continued push toward and potentially beyond recent highs over the next 11 months.
• Bear Case: Three of the four flagged contracts are puts. The near-term $242.50 put expiring July 31, 2026 saw 571 contracts trade at 656% of open interest, suggesting a trader is hedging or outright betting on a pullback of roughly 5% within the next nine days. The two December 2028 puts at $250 and $195 add longer-dated downside exposure, with the $195 strike sitting well below the 52-week low of $162.78, pointing to tail-risk hedging by at least one participant.

The forward setup for JNJ is mixed but leans constructive on the technical side. The stock's 2.03% gain today and proximity to its 52-week high of $269.43 suggest momentum is present, but the cluster of put activity, particularly the aggressive near-term $242.50 put with nine days to expiration, warns that not all smart money is aligned to the upside. The split between one very large bullish call and three bearish put positions reflects broader uncertainty in the market around JNJ's near-term trajectory. Investors will want to watch whether today's price strength can hold and build into a challenge of that 52-week high, or whether the put buyers prove prescient heading into the end of July.

JNJ Unusual Options Activity

• Contract 1: Call | Strike: $230 | Expiry: June 17, 2027 | Volume: 290 | Open Interest: 236% | Status: In-the-Money | Premium: $1,113,600
• Contract 2: Put | Strike: $242.50 | Expiry: July 31, 2026 | Volume: 571 | Open Interest: 656% | Status: Out-of-the-Money | Premium: $38,885.10
• Contract 3: Put | Strike: $250 | Expiry: December 15, 2028 | Volume: 20 | Open Interest: 1,000% | Status: Out-of-the-Money | Premium: $57,400
• Contract 4: Put | Strike: $195 | Expiry: December 15, 2028 | Volume: 40 | Open Interest: 4,000% | Status: Out-of-the-Money | Premium: $42,400

JNJ Seasonality

Late July options activity in JNJ has historically coincided with the company's second-quarter earnings reporting window, a period that can generate elevated volatility and directional positioning from institutional traders. The aggressive open interest readings across multiple contracts suggest this flow may be tied to an anticipated catalyst rather than routine hedging.

JNJ Relative Performance

JNJ's 2.03% gain today places it among the stronger performers in the large-cap healthcare space on a session basis. Trading at $255.75 against a 52-week low of $162.78 and a high of $269.43, the stock has recovered significantly from its yearly trough and is now within approximately 5.4% of its 52-week peak, a position of relative technical strength compared to many of its pharmaceutical and diversified healthcare peers.